University of Aarhus: Diabetes Mellitus, Type 2 trials
The registry lists 49 Diabetes Mellitus, Type 2 studies with University of Aarhus as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 3Phase 3 1Phase 4 3No phase 42(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- PRODIAP - Patient-reported Outcomes in General Practice Among People With Type 2 DiabetesRecruitingNCT07767331Not applicable
- Glucagon Resistance in Patients With MASLD and T2DMRecruitingNCT07246421Not applicable
- Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.RecruitingNCT07026539Phase 4
- LIVING - Physical Activity in a Self-management Program Among Persons With Type 2 DiabetesNot yet recruitingNCT06091501Not applicable
- Polyamine Treatment in Elderly Patients With Coronary Artery DiseaseCompletedNCT06186102Phase 2
- Problem-Solving Therapy for Patients With Chronic Disease and Poor Mental Well-being in General PracticeCompletedNCT05611112Not applicable
- Bone Turnover in Type 2 Diabetes and Non-diabetes Controls (DiaMarv)CompletedNCT05585697
- Specialist Conferences Between General Practitioners and EndocrinologistsCompletedNCT05268081Not applicable
- Keto Drinks as a Meal Primer in Patients With Type 2 DiabetesCompletedNCT05263401Not applicable
- Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.CompletedNCT05236335Not applicable
- Validation of 3-[11C]-OHBCompletedNCT05232812Not applicable
- Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)CompletedNCT05159570Not applicable
- Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLDCompletedNCT05044130Not applicable
- Mechanisms Behind Severe Insulin Resistance During Pregnancy in Women With Glucose Metabolic Disorders (SIR-MET)Status unknownNCT04924504
- Acute Effects of Cafestol on Glucose Metabolism in Subjects With Type-2-diabetes.CompletedNCT04908904Not applicable
- High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 DiabetesCompletedNCT04702672Not applicable
- Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLDCompletedNCT04698486Not applicable
- In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part ATerminatedNCT04650945Not applicable
- Aronia in the Type 2 Diabetes Treatment RegimenStatus unknownNCT04647175Not applicable
- Acute Studies on the Glycemic Index After Intake of Different Sorts of Barley in Subjects With Type 2 DiabetesCompletedNCT04646746Not applicable
- In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part BTerminatedNCT04630925Not applicable
- Hormonal and Inflammatory Changes During Pregnancy in Women With Glucose Metabolic Disorders.Status unknownNCT04617405
- Novel Organic Kale Products for Prevention of Obesity/Type 2 DiabetesCompletedNCT04298970Not applicable
- 24-hour Blood Pressure Dynamics and Autonomic Adrenergic Regulation in Type 2 DiabeticsStatus unknownNCT04208295
- Metabolic Effects of Whey Compounds in Patients With Diabetes Mellitus Type 2.CompletedNCT04166760Not applicable
- Metabolic Effects of Melatonin TreatmentCompletedNCT03859934Phase 1
- Community Based Management of Diabetes in NepalCompletedNCT03304158Not applicable
- The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 SecretionCompletedNCT02796950Not applicable
- Effect of Roux-en-Y Gastric Bypass or Gastric Sleeve Surgery on Type 2 DiabetesCompletedNCT02713555Not applicable
- Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic PatientsCompletedNCT02625649
- Ready to Act - Health Education in People With HyperglycaemiaCompletedNCT01945645Not applicable
- Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 DiabetesCompletedNCT01812811
- Effects of Liraglutide on Kidney Function in Type 2 Diabetic PatientsCompletedNCT01664676Phase 4
- The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride MetabolismCompletedNCT01564550
- Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic PatientsCompletedNCT01538290
- Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth"CompletedNCT01472666Not applicable
- A Practice-nurse Addressed Intervention to Improve Type 2 Diabetes CareCompletedNCT01187069Not applicable
- Nighttime Dosing of Antihypertensive Drugs in Type 2 DiabetesCompletedNCT01158625Not applicable
- VLDL-triglyceride Kinetics in Type 2 DiabetesCompletedNCT01037647
- Metabolic Effects of Vitamin D in Patients With Type 2 DiabetesCompletedNCT00812578Phase 2
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PETCompletedNCT00747968Phase 2/3
- Vitamin D and Type 2 Diabetes - a Cross Sectional StudyCompletedNCT00695474
- Immune Profile and Complication Risk in Type 2 DiabetesStatus unknownNCT00674271
- Severe Insulin Resistance in Patients With Type 2 DiabetesCompletedNCT00654056Not applicable
- The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT00653510Not applicable
- Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 DiabetesCompletedNCT00471549Phase 4
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During HypoglycemiaCompletedNCT00418288Not applicable
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy MenCompletedNCT00256256Not applicable
- The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care.CompletedNCT00237549Not applicable